Smart Microneedle Platforms: Integrating Biosensing, Artificial Intelligence, and Targeted Drug Delivery for Better Therapeutic Outcome
Materials Today Communications · 2026-11 · 116620
DOI: 10.1016/j.mtcomm.2026.116620 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Communications, 2026-11. Verfasst von Akshay Kumar und 7 weiteren Autor:innen. Die Arbeit nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Smart microneedle platforms are innovative biomedical systems that integrate biosensing, artificial intelligence (AI), and targeted drug delivery into a single minimally invasive technology. These micro-scale needle arrays can painlessly penetrate the outer skin layer to access interstitial fluid, enabling continuous and real-time monitoring of key biochemical markers such as glucose, metabolites, and disease-related biomarkers. Recent advancements in nanomaterials, microfabrication techniques, and biofunctional coatings have significantly improved their sensitivity, stability, and multifunctional performance. The incorporation of AI further enhances these systems by enabling advanced data analysis, pattern recognition, and predictive health monitoring, which supports early disease detection and personalized treatment strategies. In addition to diagnostics, smart microneedles are highly effective for controlled and targeted drug delivery, including insulin, vaccines, and anticancer therapeutics, thereby improving treatment efficiency while minimizing systemic side effects. Stimuli-responsive materials also allow these devices to release drugs in response to physiological changes such as pH, temperature, or glucose levels, enabling feedback-controlled therapy. Despite their significant potential, challenges such as large-scale manufacturing, long-term biocompatibility, regulatory approval, and data security must still be addressed. Overall, smart microneedle platforms represent a powerful convergence of biosensing, AI, and precision therapeutics, offering a promising pathway toward next-generation personalized, real-time, and minimally invasive healthcare systems.
Zitieren
APA
Kumar, A., Agrawal, M., Mahmood, S., Ghosal, K., Kumar, M., Choudhary, N., Kumar, D., & Jaganathan, R. (2026). Smart Microneedle Platforms: Integrating Biosensing, Artificial Intelligence, and Targeted Drug Delivery for Better Therapeutic Outcome. Materials Today Communications, 116620. https://doi.org/10.1016/j.mtcomm.2026.116620
Vancouver
Kumar A, Agrawal M, Mahmood S, Ghosal K, Kumar M, Choudhary N, et al. Smart Microneedle Platforms: Integrating Biosensing, Artificial Intelligence, and Targeted Drug Delivery for Better Therapeutic Outcome. Materials Today Communications. 2026:116620. doi:10.1016/j.mtcomm.2026.116620
BibTeX
@article{Kumar2026,
author = {Kumar, Akshay and Agrawal, Mohit and Mahmood, Syed and Ghosal, Kajal and Kumar, Mohit and Choudhary, Neeraj and Kumar, Dinesh and Jaganathan, Ravindran},
title = {Smart Microneedle Platforms: Integrating Biosensing, Artificial Intelligence, and Targeted Drug Delivery for Better Therapeutic Outcome},
journal = {Materials Today Communications},
year = {2026},
pages = {116620},
doi = {10.1016/j.mtcomm.2026.116620}
}
EUVIMED